The platform plans to launch a crypto lending market, personal finance app, and a stablecoin called USD1. Ethereum's Vitalik Buterin has voiced concerns about political figures using tokens as covert fundraising or influence tools. Feel unsure about the market's next move?

Federated Hermes' Kathryn Glass wasn't always set on a career in finance.

Tom Lee believes the stock market is showing signs of bottoming this week. "I think investors are a little too scared heading into Wednesday," Lee says. The 'Trade of the Day' is now live. Get a high-probability setup with clear entry and exit points right here.

The Tokyo-based company started buying Bitcoin as a "core treasury reserve asset" last year.

HC Wainwright initiated coverage on Virax Biolabs with a Buy rating and a $3 price target, citing strong market potential. ViraxImmune platform aims to diagnose T-cell exhaustion in post-viral syndromes, with FDA discussions set for mid-2025. The 'Trade of the Day' is now live.

Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund ( the Fund ) for the twelve months of 2024. The financial results remained unchanged compared to the preliminary disclosure on 17 February 2025.

Minneapolis, USA, March 31, 2025 ( GLOBE NEWSWIRE ) -- Reiterating its support for Proof-of- Work ( PoW ) mining-a practice that advances the larger cryptocurrency sector-the U.S.

Deep-pocketed investors have adopted a bearish approach towards Atlassian TEAM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

Vertex will not advance VX-264 trials after the study failed to meet efficacy endpoints, despite being generally safe and well tolerated. Zimislecel, Vertex's islet cell therapy, remains on track for Phase 3 completion in 2025, with regulatory submissions expected in 2026.

NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Atkore Inc. ATKR between August 2, 2022 and February 3, 2025, both dates inclusive ( the "Class Period" ) , of the important April 23, 2025 lead ...